{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36225979", "DateCompleted": {"Year": "2022", "Month": "10", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "03"}], "Language": ["eng"], "ELocationID": ["4661491", "10.1155/2022/4661491"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Identification of Concomitant Inhibitors against Glutamine Synthetase and Isocitrate Lyase in <i>Mycobacterium tuberculosis</i> from Natural Sources.", "Pagination": {"StartPage": "4661491", "MedlinePgn": "4661491"}, "Abstract": {"AbstractText": ["Tuberculosis (T.B.) is a disease that occurs due to infection by the bacterium, <i>Mycobacterium tuberculosis</i> (Mtb), which is responsible for millions of deaths every year. Due to the emergence of multidrug and extensive drug-resistant Mtb strains, there is an urgent need to develop more powerful drugs for inclusion in the current tuberculosis treatment regime. In this study, 1778 molecules from four medicinal plants, <i>Azadirachta indica</i>, <i>Camellia sinensis</i>, <i>Adhatoda vasica,</i> and <i>Ginkgo biloba,</i> were selected and docked against two chosen drug targets, namely, Glutamine Synthetase (G.S.) and Isocitrate Lyase (I.C.L.). Molecular Docking was performed using the Glide module of the Schr\u04e7dinger suite to identify the best-performing ligands; the complexes formed by the best-performing ligands were further investigated for their binding stability via Molecular Dynamics Simulation of 100\u2009ns. The present study suggests that Azadiradione from <i>Azadirachta indica</i> possesses the potential to inhibit Glutamine Synthetase and Isocitrate Lyase of <i>M. tuberculosis</i> concomitantly. The excellent docking score of the ligand and the stability of receptor-ligand complexes, coupled with the complete pharmacokinetic profile of Azadiradione, support the proposal of the small molecule, Azadiradione as a novel antitubercular agent. Further, wet lab analysis of Azadiradione may lead to the possible discovery of a novel antitubercular drug."], "CopyrightInformation": "Copyright \u00a9 2022 Anesha Chanda et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Electronics and Information Technology, Guwahati, 781008 Assam, India."}], "LastName": "Chanda", "ForeName": "Anesha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Gauhati University, Jalukbari, Guwahati, 781014 Assam, India."}], "LastName": "Kalita", "ForeName": "Sanjib", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea."}], "LastName": "Mishra", "ForeName": "Awdhesh Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Electronics and Information Technology, Guwahati, 781008 Assam, India."}], "LastName": "Changkakoti", "ForeName": "Liza", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Assam Science and Technology University, Jalukbari, Guwahati, 781014 Assam, India."}], "LastName": "Sarma", "ForeName": "Janayita Biswa", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Nanoscience & Nanotechnology International Research Centre, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, Rajiv Gandhi Salai, Chennai 600119, India."}], "LastName": "Biswas", "ForeName": "Kunal", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Mangaldai College, Mangaldai, 784125 Assam, India."}], "LastName": "Kakati", "ForeName": "Debashree", "Initials": "D"}, {"Identifier": ["0000-0002-6547-7227"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Biology, School of Biological Sciences, University of Science and Technology Meghalaya, 9th Mile, Techno city, Baridua, Ri-Bhoi, 793101 Meghalaya, India."}], "LastName": "Mohanta", "ForeName": "Yugal Kishore", "Initials": "YK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Gauhati University, Jalukbari, Guwahati, 781014 Assam, India."}], "LastName": "Tanti", "ForeName": "Bhaben", "Initials": "B"}, {"Identifier": ["0000-0002-5118-9945"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Electronics and Information Technology, Guwahati, 781008 Assam, India."}], "LastName": "Mahanta", "ForeName": "Saurov", "Initials": "S"}, {"Identifier": ["0000-0002-1480-3555"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Division of Biomedical Sciences, Mekelle University, Ethiopia."}, {"Identifier": [], "Affiliation": "AMR and Nanotherapeutics Laboratory, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, India."}], "LastName": "Saravanan", "ForeName": "Muthupandian", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Limonins"}, {"RegistryNumber": "0", "NameOfSubstance": "azadiradione"}, {"RegistryNumber": "EC 4.1.3.1", "NameOfSubstance": "Isocitrate Lyase"}, {"RegistryNumber": "EC 6.3.1.2", "NameOfSubstance": "Glutamate-Ammonia Ligase"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antitubercular Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutamate-Ammonia Ligase"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Isocitrate Lyase"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Limonins"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mycobacterium tuberculosis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Tuberculosis"}], "CoiStatement": "The authors declare that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cobelens F. G. J., van Deutekom H., Draayer-Jansen I. W. E., et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet . 2000;356(9228):461\u2013465. doi: 10.1016/S0140-6736(00)02554-X.", "ArticleIdList": ["10.1016/S0140-6736(00)02554-X", "10981889"]}, {"Citation": "Keshavjee S., Farmer P. E. Tuberculosis, drug resistance, and the history of modern medicine. The New England Journal of Medicine . 2012;367(10):931\u2013936. doi: 10.1056/NEJMra1205429.", "ArticleIdList": ["10.1056/NEJMra1205429", "22931261"]}, {"Citation": "World Health Organization. Global tuberculosis report . World Health Organization; 2015."}, {"Citation": "Horsburgh C. R., Barry C. E., Lange C. Treatment of tuberculosis. The New England Journal of Medicine . 2015;373(22):2149\u20132160. doi: 10.1056/NEJMra1413919.", "ArticleIdList": ["10.1056/NEJMra1413919", "26605929"]}, {"Citation": "McDermott W., McCune R., Jr., Tompsett R. Dynamics of antituberculous chemotherapy. American Review of Tuberculosis and Pulmonary Diseases . 1956;74(2):100\u2013108.", "ArticleIdList": ["13340169"]}, {"Citation": "Hu Y., Coates A. R., Mitchison D. A. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis. The International Journal of Tuberculosis and Lung Disease . 2006;10(3):317\u2013322.", "ArticleIdList": ["16562713"]}, {"Citation": "Comas I., Gagneux S. The past and future of tuberculosis research. PLoS Pathogens . 2009;5(10):1\u20137. doi: 10.1371/journal.ppat.1000600.", "ArticleIdList": ["10.1371/journal.ppat.1000600", "PMC2745564", "19855821"]}, {"Citation": "Schatz A., Bugle E., Waksman S. A. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria\u2217. Proceedings of the Society for Experimental Biology and Medicine . 1944;55(1):66\u201369. doi: 10.3181/00379727-55-14461.", "ArticleIdList": ["10.3181/00379727-55-14461"]}, {"Citation": "Chetty S., Ramesh M., Singh-Pillay A., Soliman M. E. S. Recent advancements in the development of anti-tuberculosis drugs. Bioorganic & Medicinal Chemistry Letters . 2017;27(3):370\u2013386. doi: 10.1016/j.bmcl.2016.11.084.", "ArticleIdList": ["10.1016/j.bmcl.2016.11.084", "28017531"]}, {"Citation": "Goldman L., Schafer A. Goldman's cecil medicine: expert consult premium edition . 24th. St. Louis (MO): Saunders Elsevier; 2011. Tuberculosis: disease overview."}, {"Citation": "Singh B., Bhat T. K., Singh B. Potential therapeutic applications of some antinutritional plant secondary metabolites. Journal of Agricultural and Food Chemistry . 2003;51(19):5579\u20135597. doi: 10.1021/jf021150r.", "ArticleIdList": ["10.1021/jf021150r", "12952405"]}, {"Citation": "Kumar S., Sharma X. C., Kaushik S. R., Kulshreshtha A., Chaturvedi S., Dwivedi V. P. The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice. The Journal of Biological Chemistry . 2019;294(21):8555\u20138563. doi: 10.1074/jbc.RA119.008005.", "ArticleIdList": ["10.1074/jbc.RA119.008005", "PMC6544861", "30975902"]}, {"Citation": "Singh N., Siddiqi M. I. Computational evaluation of glutamine synthetase as drug target against infectious diseases: molecular modeling, substrate-binding analysis, and molecular dynamics simulation studies. Medicinal Chemistry Research . 2017;26(2):450\u2013460. doi: 10.1007/s00044-016-1766-9.", "ArticleIdList": ["10.1007/s00044-016-1766-9"]}, {"Citation": "Mu\u00f1oz-El\u00edas E. J., McKinney J. D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nature Medicine . 2005;11(6):638\u2013644. doi: 10.1038/nm1252.", "ArticleIdList": ["10.1038/nm1252", "PMC1464426", "15895072"]}, {"Citation": "Harth G., Clemens D. L., Horwitz M. A. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proceedings of the National Academy of Sciences of the United States of America . 1994;91(20):9342\u20139346. doi: 10.1073/pnas.91.20.9342.", "ArticleIdList": ["10.1073/pnas.91.20.9342", "PMC44808", "7937767"]}, {"Citation": "Berlicki L., Kafarski P. Computer-aided analysis of the interactions of glutamine synthetase with its inhibitors. Bioorganic & Medicinal Chemistry . 2006;14(13):4578\u20134585. doi: 10.1016/j.bmc.2006.02.022.", "ArticleIdList": ["10.1016/j.bmc.2006.02.022", "16504520"]}, {"Citation": "Harth G., Horwitz M. A. Inhibition ofMycobacterium tuberculosisglutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo. Infection and Immunity . 2003;71(1):456\u2013464. doi: 10.1128/IAI.71.1.456-464.2003.", "ArticleIdList": ["10.1128/IAI.71.1.456-464.2003", "PMC143262", "12496196"]}, {"Citation": "Tullius M. V., Harth G., Horwitz M. A. High extracellular levels ofMycobacterium tuberculosisglutamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism. Infection and Immunity . 2001;69(10):6348\u20136363. doi: 10.1128/IAI.69.10.6348-6363.2001.", "ArticleIdList": ["10.1128/IAI.69.10.6348-6363.2001", "PMC98770", "11553579"]}, {"Citation": "Gordon A. H., Hart P. D., Young M. R. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature . 1980;286(5768):79\u201380. doi: 10.1038/286079a0.", "ArticleIdList": ["10.1038/286079a0", "6993961"]}, {"Citation": "Vanni P., Giachetti E., Pinzauti G., McFadden B. A. Comparative structure, function and regulation of isocitrate lyase, an important assimilatory enzyme. Comparative Biochemistry and Physiology. B . 1990;95(3):431\u2013458. doi: 10.1016/0305-0491(90)90002-B.", "ArticleIdList": ["10.1016/0305-0491(90)90002-B", "2184988"]}, {"Citation": "Dunn M. F., Ram\u00edrez-Trujillo J. A., Hern\u00e1ndez-Lucas I. Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiology . 2009;155(10):3166\u20133175. doi: 10.1099/mic.0.030858-0.", "ArticleIdList": ["10.1099/mic.0.030858-0", "19684068"]}, {"Citation": "Brahmachari G. Neem\u2014an omnipotent plant: a retrospection. Chembiochem . 2004;5(4):408\u2013421. doi: 10.1002/cbic.200300749.", "ArticleIdList": ["10.1002/cbic.200300749", "15185362"]}, {"Citation": "Claeson U. P., Malmfors T., Wikman G., Bruhn J. G. Adhatoda vasica : a critical review of ethnopharmacological and toxicological data. Journal of Ethnopharmacology . 2000;72(1\u20132):1\u201320. doi: 10.1016/S0378-8741(00)00225-7.", "ArticleIdList": ["10.1016/S0378-8741(00)00225-7", "10967448"]}, {"Citation": "Diamond B. J., Shiflett S. C., Feiwel N., et al. Ginkgo biloba extract: mechanisms and clinical indications. Archives of Physical Medicine and Rehabilitation . 2000;81(5):668\u2013678.", "ArticleIdList": ["10807109"]}, {"Citation": "Hamilton-Miller J. M. Antimicrobial properties of tea (Camellia sinensis L.) Antimicrobial Agents and Chemotherapy . 1995;39(11):2375\u20132377. doi: 10.1128/AAC.39.11.2375.", "ArticleIdList": ["10.1128/AAC.39.11.2375", "PMC162950", "8585711"]}, {"Citation": "Martyna G. J., Tuckerman M. E., Tobias D. J., Klein M. L. Explicit reversible integrators for extended systems dynamics. Molecular Physics . 1996;87(5):1117\u20131157. doi: 10.1080/00268979600100761.", "ArticleIdList": ["10.1080/00268979600100761"]}, {"Citation": "Cheng F., Li W., Zhou Y., et al. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling . 2012;52(11):3099\u20133105. doi: 10.1021/ci300367a.", "ArticleIdList": ["10.1021/ci300367a", "23092397"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports . 2017;7(1):1\u201313. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Lagorce D., Douguet D., Miteva M. A., Villoutreix B. O. Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Scientific Reports . 2017;7(1, article 46277) doi: 10.1038/srep46277.", "ArticleIdList": ["10.1038/srep46277", "PMC5387685", "28397808"]}, {"Citation": "Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews . 1997;23(1-3):3\u201325. doi: 10.1016/S0169-409X(96)00423-1.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Daina A., Zoete V. A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem . 2016;11(11):1117\u20131121. doi: 10.1002/cmdc.201600182.", "ArticleIdList": ["10.1002/cmdc.201600182", "PMC5089604", "27218427"]}, {"Citation": "Kushwaha P., Khedgikar V., Haldar S., et al. Azadirachta indica triterpenoids promote osteoblast differentiation and mineralization in vitro and in vivo. Bioorganic & Medicinal Chemistry Letters . 2016;26(15):3719\u20133724. doi: 10.1016/j.bmcl.2016.05.076.", "ArticleIdList": ["10.1016/j.bmcl.2016.05.076", "27317644"]}, {"Citation": "Singh R., Mishra V., Pandeti S., et al. Cytoprotective and anti-secretory effects of azadiradione isolated from the seeds of Azadirachta indica (neem) on gastric ulcers in rat models. Phytotherapy Research . 2015;29(6):910\u2013916. doi: 10.1002/ptr.5332.", "ArticleIdList": ["10.1002/ptr.5332", "25851068"]}, {"Citation": "Morris G. M., Huey R., Olson A. J. Using AutoDock for ligand-receptor docking. Current Protocols in Bioinformatics . 2008;24(1):8\u201314. doi: 10.1002/0471250953.bi0814s24.", "ArticleIdList": ["10.1002/0471250953.bi0814s24", "19085980"]}, {"Citation": "Quiroga R., Villarreal M. A. Vinardo: a scoring function based on Autodock Vina improves scoring, docking, and virtual screening. PLoS One . 2016;11(5, article e0155183) doi: 10.1371/journal.pone.0155183.", "ArticleIdList": ["10.1371/journal.pone.0155183", "PMC4865195", "27171006"]}, {"Citation": "Biesiada J., Porollo A., Velayutham P., Kouril M., Meller J. Survey of public domain software for docking simulations and virtual screening. Human Genomics . 2011;5(5):497\u2013505. doi: 10.1186/1479-7364-5-5-497.", "ArticleIdList": ["10.1186/1479-7364-5-5-497", "PMC3525969", "21807604"]}, {"Citation": "Porollo A., Meller J. POLYVIEW-MM: web-based platform for animation and analysis of molecular simulations. Nucleic Acids Research . 2010;38(Supplement_2):W662\u2013W666. doi: 10.1093/nar/gkq445.", "ArticleIdList": ["10.1093/nar/gkq445", "PMC2896192", "20504857"]}, {"Citation": "Seeliger D., de Groot B. L. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular Design . 2010;24(5):417\u2013422. doi: 10.1007/s10822-010-9352-6.", "ArticleIdList": ["10.1007/s10822-010-9352-6", "PMC2881210", "20401516"]}, {"Citation": "Yuan S., Chan H. C. S., Hu Z. Using PyMOL as a platform for computational drug design. WIREs Computational Molecular Science . 2017;7(2, article e1298) doi: 10.1002/wcms.1298.", "ArticleIdList": ["10.1002/wcms.1298"]}, {"Citation": "Pettersen E. F., Goddard T. D., Huang C. C., et al. UCSF Chimera?a visualization system for exploratory research and analysis. Journal of Computational Chemistry . 2004;25(13):1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Kanehisa M., Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research . 2000;28(1):27\u201330. doi: 10.1093/nar/28.1.27.", "ArticleIdList": ["10.1093/nar/28.1.27", "PMC102409", "10592173"]}, {"Citation": "Zhang R., Lin Y. DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes. Nucleic Acids Research . 2009;37:D455\u2013D458. doi: 10.1093/nar/gkn858.", "ArticleIdList": ["10.1093/nar/gkn858", "PMC2686491", "18974178"]}, {"Citation": "Nilsson M. T., Krajewski W. W., Yellagunda S., et al. Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors. Journal of Molecular Biology . 2009;393(2):504\u2013513. doi: 10.1016/j.jmb.2009.08.028.", "ArticleIdList": ["10.1016/j.jmb.2009.08.028", "19695264"]}, {"Citation": "Mahanta S., Chowdhury P., Gogoi N., et al. Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach. Journal of Biomolecular Structure and Dynamics . 2021;39(10):3802\u20133811. doi: 10.1080/07391102.2020.1768902.", "ArticleIdList": ["10.1080/07391102.2020.1768902", "32406317"]}, {"Citation": "Mowbray S. L., Kathiravan M. K., Pandey A. A., Odell L. R. Inhibition of glutamine synthetase: a potential drug target in Mycobacterium tuberculosis. Molecules . 2014;19(9):13161\u201313176. doi: 10.3390/molecules190913161.", "ArticleIdList": ["10.3390/molecules190913161", "PMC6271674", "25162957"]}, {"Citation": "Lee Y.-V., Wahab H. A., Choong Y. S. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary. BioMed Research International . 2015;2015:20. doi: 10.1155/2015/895453.895453", "ArticleIdList": ["10.1155/2015/895453", "PMC4306415", "25649791"]}, {"Citation": "Sharma V., Sharma S., zu Bentrup K. H., et al. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nature Structural Biology . 2000;7(8):663\u2013668. doi: 10.1038/77964.", "ArticleIdList": ["10.1038/77964", "10932251"]}, {"Citation": "Dallakyan S., Olson A. J. Small-molecule library screening by docking with PyRx. In: Hempel J., Williams C., Hong C., editors. Chemical biology . Vol. 1263. New York, NY: Humana Press; 2015. pp. 243\u2013250. (Methods in Molecular Biology).", "ArticleIdList": ["10.1007/978-1-4939-2269-7_19", "25618350"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "11"}, {"Year": "2022", "Month": "8", "Day": "5"}, {"Year": "2022", "Month": "8", "Day": "23"}, {"Year": "2022", "Month": "10", "Day": "13", "Hour": "2", "Minute": "43"}, {"Year": "2022", "Month": "10", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["36225979", "PMC9550479", "10.1155/2022/4661491"]}}], "PubmedBookArticle": []}